Protein Purification Meets Automation: Driving Efficiency in Biopharma
Developing advanced therapies and vaccines depends on reliable and cost-effective protein purification. As treatments like bispecific antibodies and gene and cell therapies become more common, the need for fast, scalable purification methods is growing. This article explores how automating these workflows helps streamline operations, cut down on manual errors, and reduce the time scientists spend on hands-on tasks, featuring insights from Lars Kristiansen, Vice President of Product Innovation and Strategy at Molecular Devices.